isosorbide-5-mononitrate has been researched along with Coronary Disease in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (61.18) | 18.7374 |
| 1990's | 24 (28.24) | 18.2507 |
| 2000's | 8 (9.41) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (1.18) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, G; Liu, X; Xu, J; Zhang, G | 1 |
| Münzel, T | 1 |
| George, J; Golovner, M; Kitzis, I; Laniado, S; Roth, A; Shapira, I; Zandorf, D | 1 |
| Kloner, RA | 1 |
| Lemmer, B | 1 |
| Dietmann, K; Sponer, G; Voss, E | 1 |
| Glocke, M; Müller, G; Uberbacher, HJ | 1 |
| Haase, W; van Hasselt, P; Weiss, M | 1 |
| Blasini, R; Brügmann, U; Reiniger, G; Rudolph, W | 1 |
| Abshagen, U; Glocke, M; Uberbacher, HJ | 1 |
| Häcker, W; Müller, G; Schneider, B | 1 |
| Kayali, A | 1 |
| Jansen, W; Metternich, M; Osterspey, A; Tauchert, M | 1 |
| Haase, W; van Hasselt, M; Weiss, M | 1 |
| Haase, W; Marten, W; Weiss, M | 1 |
| Bussmann, WD; Kaltenbach, M; Schneider, W; Stahl, B | 1 |
| Jahed, M | 1 |
| Fuchs, M; Hilger, HH; Hombach, V; Jansen, W; Osterspey, A; Tauchert, M | 1 |
| Schuster, P; Trieb, G; Wiechmann, HW | 2 |
| Bartsch, W; Dietmann, K; Müller-Beckmann, B; Sponer, G; Strein, K | 1 |
| Glocke, M; Seeliger, S; Smolarz, A | 1 |
| Fuchs, M; Hombach, V; Jansen, W; Osterspey, A; Schell, U; Tauchert, M; Weste, S | 1 |
| Kochsiek, K; Schanzenbächer, P | 1 |
| Bergbauer, M | 1 |
| Schmidt, G | 1 |
| Fuchs, M; Hilger, HH; Hombach, V; Jansen, W; Osterspey, A; Schell, U; Schmid, G; Tauchert, M | 1 |
| Abshagen, U; Gleichmann, U; Mannebach, H; Ohlmeier, H; von Möllendorff, E | 1 |
| Kübler, W; Manthey, J; Mehmel, HC; Ruffmann, K; Schwarz, F | 1 |
| Doering, W; Greding, H; Isbary, J; König, E; Wauer, B | 1 |
| Müller, G; Schmidt-Voigt, J | 1 |
| Brandt, D; Dorda, W; Pichler, M; Teubl, H | 1 |
| Kedzia, E; Krzemińska-Pakuła, M; Kurpesa, M; Musiał, W; Peruga, Z; Trzos, E | 1 |
| Amado, JA; Berrazueta, JR; Ochoteco, A; Poveda, JJ; Riestra, A; Salas, E | 1 |
| Bartoli, E; De Carli, S; Sechi, LA; Zingaro, L | 1 |
| Bruno, G; Cordovil, A; Dodi, C; Picano, E; Pingitore, A; Sicari, R | 1 |
| Abete, P; Acanfora, D; Ferrara, N; Furgi, G; Iannuzzi, GL; Leosco, D; Longobardi, G; Nicolino, A; Pinna, G; Rengo, F | 1 |
| Alekseeva, IA; Chotchaev, KhKh; Lupanov, VP; Naumov, VG; Vasil'eva, NN | 1 |
| Cleophas, TJ; Jansen, R; Niemeyer, MG; Zwinderman, AH | 1 |
| Ikeda, N; Ino, T; Saito, M; Yamada, S; Yasu, T | 1 |
| Kurosaki, M; Latini, R; Riva, E | 1 |
| Döring, G | 1 |
| D'Aprile, N; Faglia, S; Kristodhullo, A; Mondillo, S; Palazzuoli, V | 1 |
| Düring, C; Geppert, R; Jansen, W; Prenzel, R; Rappert, B | 1 |
| Ganzinger, U | 1 |
| Gessner, C; Hain, P; Mitrovic, V; Müller, KD; Schlepper, M | 1 |
| Ahmadinejad, M; Eghbal, B; Ensslin, HD; May, K; Weiss, M | 1 |
| Keck, M | 1 |
| Jansen, W; Kümper, H; Laufen, H; Prenzel, R; Rappert, B; Tauchert, M | 1 |
| Bachmann, K; Wortmann, A | 2 |
| Hůla, J; Trhlíková, M | 1 |
| Heidemann, HT; Meissner, A; Osterkamp, U; Petersenn, S; Schulte, HM; Simon, R | 1 |
| Jansen, W; Tauchert, M | 1 |
| Avila Escribano, C; Cascón Bueno, M; Diego Domínguez, M; Fernández Esteban, T; Martín Luengo, C; Nieto Ballesteros, F; Pavón Osuna, P; Santos Rodríguez, I | 1 |
| Silber, S | 1 |
| Beyerle, A; Reiniger, G; Rudolph, W | 1 |
| Bernini, W; De Caterina, R; Giannessi, D; Lazzerini, G; Lombardi, M; Mazzone, A; Moscarelli, E; Weiss, M | 1 |
| Jansen, W; Kümper, H; Prenze, R; Tauchert, M | 1 |
| Jansen, W; Kümper, H; Prenzel, R; Tauchert, M; Weidmann, B | 1 |
| Beyerle, A; Dirschinger, J; Reiniger, G; Rudolph, W | 1 |
| Behrenbeck, T; Bender, F; Brisse, B; Ebert, U; Navah, R | 1 |
| Boertz, A; Bonn, R; Cawello, W; Dickmans, HA; Evers, J; Weiss, M | 1 |
| Johnen, R; Neuhaus, R; Solbach, C; Vydra, L | 1 |
| Ambrosioni, E; Strocchi, E | 1 |
| Bleifeld, W; Erlemeier, HH; Hempel, NB; Kupper, W | 1 |
| Erath, A; von Arnim, T | 1 |
| Gathmann-Lewik, U; Kenedi, P | 1 |
| Jansen, W; Meyer, L; Tauchert, M | 1 |
| Calvi, V; Felis, S; Giuffrida, G; Grassi, R; Greco, G; Monaco, A; Monaco, O; Russo, G; Tamburino, C; Tolaro, S | 1 |
| Geppert, R; Jansen, W; Tauchert, M; Weidmann, B | 1 |
| Burkhardt, H; Deuster, U; Loew, D; Rietbrock, N | 1 |
| Kanto, JH | 1 |
| Distante, A; L'Abbate, A; Lombardi, M; Morales, MA; Moscarelli, E | 1 |
| Marks, C; Stephens, JD; Vandenburg, MJ; Woodings, D | 1 |
| Hutton, I; Martin, W; McGhie, AI; Tweddel, AC | 1 |
| Agranat, O; Chouraqui, P; Hod, H; Neufeld, HN; Rabinowitz, B; Rath, S | 1 |
| Eggeling, T; Hilger, HH; Jansen, W; Osterspey, A; Tauchert, M | 1 |
| Grosswendt, J; Klütsch, K; Koch, E; Schöniger, F | 1 |
| Gleichmann, U; Kabelitz, K; Mannebach, H; Mertens, HM; Ohlmeier, H | 1 |
| Akhras, F; Jackson, G; Jefferies, S | 1 |
| Kozák, P | 1 |
| Thadani, U | 1 |
| Distante, A; L'Abbate, A; Lombardi, M; Morales, MA; Moscarelli, E; Sabino, F | 1 |
6 review(s) available for isosorbide-5-mononitrate and Coronary Disease
| Article | Year |
|---|---|
[Recent findings on nitrates: their action, bioactivation and development of tolerance].
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Coronary Disease; Drug Tolerance; Endothelium, Vascular; Guanylate Cyclase; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Molsidomine; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Oxidative Stress; Pentaerythritol Tetranitrate; Reactive Oxygen Species; Vasodilation; Vasodilator Agents | 2008 |
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents | 2004 |
The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Coronary Disease; Diuretics; Heart Rate; Humans; Hypertension; Isosorbide Dinitrate; Mice; Time Factors | 2006 |
Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1990 |
[Long-term therapy with nitrates. How can continuous effectiveness be achieved?].
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Humans; Isosorbide Dinitrate; Nitrates | 1989 |
[Slow-release nitrates: a critical review].
Topics: Coronary Disease; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nitroglycerin | 1987 |
45 trial(s) available for isosorbide-5-mononitrate and Coronary Disease
| Article | Year |
|---|---|
Safety of nitrate withdrawal in angina-free and hemodynamically stable patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Prospective Studies; Safety; Vasodilator Agents | 2003 |
[Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Metipranolol; Middle Aged; Propanolamines | 1983 |
[Treatment of coronary disease with elantan. Results of a multicenter study].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1984 |
[Prevention of the development of tolerance to isosorbide dinitrate in interval therapy].
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Heart Rate; Humans; Isosorbide Dinitrate | 1984 |
[Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Female; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged | 1983 |
Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1983 |
[Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1983 |
Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1984 |
Differences in the production of methemoglobin during high-dose treatment with isosorbide dinitrate or isosorbide 5-mononitrate.
Topics: Adult; Coronary Disease; Humans; Isosorbide Dinitrate; Methemoglobin; Time Factors | 1984 |
[Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Topics: Adult; Aged; Coronary Disease; Delayed-Action Preparations; Female; Hemodynamics; Humans; Isosorbide; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged | 1981 |
[Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
Topics: Coronary Disease; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged | 1982 |
[5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].
Topics: Adult; Blood Pressure; Cardiac Output; Coronary Disease; Drug Tolerance; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Pulmonary Artery; Time Factors | 1982 |
[Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
Topics: Adult; Aged; Coronary Disease; Female; Humans; Isosorbide; Isosorbide Dinitrate; Kinetics; Male; Middle Aged | 1981 |
[Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
Topics: Adult; Coronary Disease; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1981 |
[The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
Topics: Aged; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Isosorbide; Isosorbide Dinitrate; Male; Middle Aged; Sorbitol | 1981 |
[Isosorbide-5-mononitrate in silent ischemia].
Topics: Adult; Aged; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Conduction System; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Vasodilator Agents | 1995 |
[Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
Topics: Adult; Coronary Disease; Delayed-Action Preparations; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Treatment Outcome; Vasodilator Agents | 1994 |
Effect of isosorbide-5-mononitrate on plasma and urine levels of cyclic GMP in relation to exercise in coronary patients compared with control subjects.
Topics: Angina Pectoris; Coronary Disease; Cyclic GMP; Exercise; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1995 |
Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
Topics: Atropine; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Diltiazem; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Exercise Test; Female; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Nitrates; Parasympatholytics; Prospective Studies; Vasodilator Agents | 1997 |
Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activity.
Topics: Aged; Analysis of Variance; Blood Pressure; Coronary Disease; Cross-Over Studies; Dipyridamole; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Prospective Studies; Vasodilator Agents | 2000 |
[Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Vasodilator Agents | 2000 |
Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis.
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Diabetes Complications; Drug Administration Schedule; Humans; Hypercholesterolemia; Isosorbide Dinitrate; Linear Models; Nitric Oxide Donors; Quality of Life; Treatment Outcome; Vasodilator Agents | 2000 |
Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Exercise; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1992 |
Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
Topics: Aged; Angina Pectoris; Circadian Rhythm; Coronary Disease; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male | 1992 |
Hemodynamic, anti-ischemic, and neurohumoral effects of slow-release isosorbide-5-mononitrate in patients with coronary artery disease after short- and long-term therapy.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Epinephrine; Heart Rate; Humans; Isosorbide Dinitrate; Middle Aged; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Placebos; Renin; Time Factors; Vasopressins; Ventricular Function, Left | 1991 |
Sustained-release IS-5-MN in the treatment of coronary heart disease.
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Monitoring, Physiologic | 1991 |
Chronotherapy in coronary heart disease: comparison of two nitrate treatments.
Topics: Aged; Circadian Rhythm; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1991 |
Circadian variation of cardiac performance in coronary heart disease.
Topics: Aged; Circadian Rhythm; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure | 1990 |
Pulmonary arterial pressure and working capacity as parameters for checking the development of tolerance under nitrate therapy.
Topics: Administration, Oral; Adult; Coronary Disease; Electrocardiography; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Pulmonary Wedge Pressure; Reproducibility of Results | 1990 |
[Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
Topics: Administration, Oral; Aged; Angina Pectoris; Coronary Disease; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Endurance; Single-Blind Method | 1990 |
Long-acting, marked antiischemic effect maintained unattenuated during long-term interval treatment with once-daily isosorbide-5-mononitrate in sustained-release form.
Topics: Blood Pressure; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Isosorbide Dinitrate; Physical Exertion; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentration and hemodynamic effects.
Topics: Coronary Disease; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 1990 |
[Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Exercise Test; Heart Rate; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Pulmonary Wedge Pressure; Vasodilator Agents | 1989 |
[Combination therapy with slow release isosorbide nitrate and diltiazem in silent myocardial ischemia].
Topics: Adult; Coronary Disease; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Randomized Controlled Trials as Topic; Vasodilator Agents | 1989 |
Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Female; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1986 |
Anti-ischemic effects of slow-release formulations of nifedipine, isosorbide-5-mononitrate and their combination in patients with coronary heart disease.
Topics: Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Random Allocation | 1988 |
Nitrates and calcium antagonists for silent myocardial ischemia.
Topics: Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Monitoring, Physiologic; Nifedipine; Random Allocation | 1988 |
Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease.
Topics: Aged; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Physical Exertion | 1988 |
[Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
[Dose-dependent serum concentration of ISDN and its metabolites following administration of ISDN-retard. Studies under steady-state conditions].
Topics: Aged; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Isosorbide Dinitrate; Male; Random Allocation | 1986 |
Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure.
Topics: Chronic Disease; Coronary Disease; Drug Therapy, Combination; Exercise Test; Felodipine; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Nitrendipine | 1987 |
Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Topics: Administration, Oral; Adult; Aged; Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Random Allocation | 1987 |
[4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Delayed-Action Preparations; Drug Tolerance; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Myocardial Contraction; Nitroglycerin | 1985 |
Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
Topics: Aged; Coronary Disease; Echocardiography; Electrocardiography; Ergonovine; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1985 |
34 other study(ies) available for isosorbide-5-mononitrate and Coronary Disease
| Article | Year |
|---|---|
Comparative analysis of cost-effectiveness between isosorbide-5-mononitrate and isosorbide: a retrospective real-world evaluation.
Topics: Administration, Sublingual; Aged; Aged, 80 and over; China; Coronary Disease; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Hypotension; Incidence; Isosorbide; Isosorbide Dinitrate; Length of Stay; Male; Middle Aged; Nitric Oxide Donors; Nitroglycerin; Pragmatic Clinical Trials as Topic; Propensity Score; Retrospective Studies; Vasodilator Agents | 2020 |
[Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Drug Therapy, Combination; Isosorbide Dinitrate; Male; Metipranolol; Propanolamines | 1981 |
[Long-term therapy with nitrates. Relation between dosage and tolerance effect].
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Middle Aged; Nitroglycerin | 1984 |
Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Nitroglycerin | 1984 |
[Elantan in coronary heart disease. Report of experiences].
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1983 |
Dose dependence of tolerance during treatment with mononitrates.
Topics: Adult; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Physical Exertion | 1983 |
Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Topics: Aged; Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1983 |
Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
Topics: Administration, Oral; Animals; Coronary Disease; Disease Models, Animal; Dogs; Electrocardiography; Exercise Test; Female; Injections, Intravenous; Isosorbide Dinitrate; Male; Time Factors | 1984 |
[Higher therapeutic safety of Mono-Nitrate. Report on the 3rd Mono-Nitrate Workshop of the Pharma-Schwarz Company, Monheim].
Topics: Animals; Coronary Disease; Delayed-Action Preparations; Dogs; Humans; Isosorbide Dinitrate | 1984 |
[Isosorbide mononitrate or dinitrate in coronary disease?].
Topics: Coronary Disease; Humans; Isosorbide Dinitrate | 1983 |
[Left ventricular function parameters following administration of isosorbide-5-mononitrate].
Topics: Coronary Disease; Echocardiography; Female; Heart Function Tests; Heart Ventricles; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1983 |
[Comparative clinical evaluation of ISDN and 5-ISMN as exemplified by Mono Mack 20 mg/40 mg].
Topics: Animals; Coronary Disease; Dogs; Drug Evaluation; Half-Life; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Rats | 1983 |
[Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
Topics: Aged; Blood Pressure; Coronary Disease; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1983 |
[Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
Topics: Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1981 |
Resolution of rate-related left bundle branch block after nitrate therapy.
Topics: Bundle-Branch Block; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Middle Aged; Valsalva Maneuver; Vasodilator Agents | 1996 |
Echocardiographical demonstration of a progressively expanding left ventricular aneurysm preceded by endomyocardial tearing.
Topics: Aged; Aneurysm, False; Antihypertensive Agents; Combined Modality Therapy; Coronary Disease; Disease Progression; Echocardiography; Endocardium; Female; Fibrin Tissue Adhesive; Heart Aneurysm; Heart Rupture; Heart Ventricles; Humans; Hypromellose Derivatives; Isosorbide Dinitrate; Methylcellulose; Myocardial Infarction; Nitroglycerin; Pericardial Effusion; Stroke Volume; Tissue Adhesives; Ventricular Remodeling | 2001 |
Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Coronary Disease; Dipeptides; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Hemodynamics; Isosorbide Dinitrate; Lisinopril; Male; Peptidyl-Dipeptidase A; Rats | 1992 |
[The association of amlodipine with isosorbide-5-mononitrate in the treatment of ischemic-hypertensive cardiopathy].
Topics: Adult; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Vasodilator Agents | 1992 |
Comparison of pharmacokinetics and pharmacodynamics of one-week monotherapy with IS-5-N s.r. 50 or 100 mg, ISDN s.r. 120 mg or IS-5-N 2 x 20 mg in coronary heart disease patients.
Topics: Blood Pressure; Coronary Disease; Humans; Isosorbide Dinitrate; Pulmonary Artery; Vasodilator Agents | 1992 |
Evaluation of effectiveness and tolerability of isosorbide mononitrate during a three-year period in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Exercise Test; Female; Headache; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Risk Factors | 1991 |
Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.
Topics: Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Exercise; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1991 |
[Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
Topics: Coronary Disease; Delayed-Action Preparations; Hemodynamics; Humans; Isosorbide Dinitrate | 1991 |
Pharmacokinetics of oral isosorbide-5-mononitrate in patients with ischemic heart failure.
Topics: Absorption; Adult; Aged; Central Venous Pressure; Chromatography, Gas; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1991 |
Interval treatment of coronary artery disease with sustained-release isosorbide-5-mononitrate.
Topics: Adult; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure | 1990 |
Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Kidney Failure, Chronic; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged | 1989 |
[Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Female; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vascular Resistance | 1988 |
Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Topics: Administration, Oral; Coronary Disease; Drug Tolerance; Half-Life; Headache; Heart Failure; Humans; Isosorbide Dinitrate; Kidney Failure, Chronic; Kinetics; Liver Cirrhosis; Male | 1987 |
Oral isosorbide 5-mononitrate can protect from myocardial ischemia induced by ergonovine test and by isometric effort. Preliminary results from an echocardiographic acute study in anginal patients.
Topics: Administration, Oral; Coronary Disease; Coronary Vasospasm; Echocardiography; Ergonovine; Humans; Isometric Contraction; Isosorbide Dinitrate | 1987 |
Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Digoxin; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1987 |
[Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
Topics: Adult; Coronary Disease; Delayed-Action Preparations; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1986 |
[Value of nitrates in modern coronary therapy].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Nitrates | 1985 |
Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Physical Exertion | 1985 |
[The duration of th effect of isosorbide-5-mononitrate--a new anti-anginal agent].
Topics: Coronary Disease; Hemodynamics; Humans; Isosorbide Dinitrate; Time Factors | 1985 |
Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Topics: Angina Pectoris; Biological Availability; Coronary Disease; Delayed-Action Preparations; Humans; Isosorbide Dinitrate | 1985 |